Financial Year |
March 31 2023 |
Monetary Funds |
1,011,942,080.12 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
4,404,125.44 |
Accounts Receivable |
712,148,347.32 |
Advances to Suppliers |
40,531,292.53 |
Other Receivables |
99,549,932.67 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
761,048,247.07 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,634,261.86 |
Other Current Assets |
51,051,291.12 |
Total Current Assets |
2,741,867,853.82 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
12,119,517.22 |
Long-term Equity Investment |
484,687,376.48 |
Investment Properties |
172,298,666.32 |
Fixed Assetes |
74,055,054.03 |
Under-construction Projects |
831,559,426.05 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
104,887,047.38 |
R&D expenses |
28,312,481.28 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
673,172.63 |
Deferred Income Tax Assets |
42,947,158.45 |
Other Non-Current Assets |
678,897.79 |
Sub-Total of Non-Current Assets |
1,752,218,797.62 |
Total Assets |
4,494,086,651.44 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
1,000,106,818.87 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
145,281,628.96 |
Taxes Payable |
7,380,608.32 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
87,479,303.61 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
42,829,514.76 |
Sub-Total of Current Liabilities |
2,256,559,353.89 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,252,452.77 |
Total Liabilities |
2,258,811,806.66 |
Paid-In Capital(Or Share Stock) |
324,098,753.00 |
Capital Surplus |
1,055,548,374.87 |
Surplus Reserve |
97,150,663.25 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
757,316,473.49 |
Minority Stockholder's Interest |
1,160,580.17 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,234,114,264.61 |
Owner's Equity(Stockholder's Equity) |
2,235,274,844.78 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,494,086,651.44 |